Correlation Between US Physicalrapy and Amedisys

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both US Physicalrapy and Amedisys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining US Physicalrapy and Amedisys into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between US Physicalrapy and Amedisys, you can compare the effects of market volatilities on US Physicalrapy and Amedisys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in US Physicalrapy with a short position of Amedisys. Check out your portfolio center. Please also check ongoing floating volatility patterns of US Physicalrapy and Amedisys.

Diversification Opportunities for US Physicalrapy and Amedisys

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between USPH and Amedisys is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding US Physicalrapy and Amedisys in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amedisys and US Physicalrapy is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on US Physicalrapy are associated (or correlated) with Amedisys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amedisys has no effect on the direction of US Physicalrapy i.e., US Physicalrapy and Amedisys go up and down completely randomly.

Pair Corralation between US Physicalrapy and Amedisys

Given the investment horizon of 90 days US Physicalrapy is expected to generate about the same return on investment as Amedisys. However, US Physicalrapy is 3.14 times more volatile than Amedisys. It trades about 0.0 of its potential returns per unit of risk. Amedisys is currently producing about 0.0 per unit of risk. If you would invest  9,259  in Amedisys on August 31, 2024 and sell it today you would lose (118.00) from holding Amedisys or give up 1.27% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

US Physicalrapy  vs.  Amedisys

 Performance 
       Timeline  
US Physicalrapy 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in US Physicalrapy are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, US Physicalrapy demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Amedisys 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amedisys has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Amedisys is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

US Physicalrapy and Amedisys Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with US Physicalrapy and Amedisys

The main advantage of trading using opposite US Physicalrapy and Amedisys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if US Physicalrapy position performs unexpectedly, Amedisys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amedisys will offset losses from the drop in Amedisys' long position.
The idea behind US Physicalrapy and Amedisys pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm